冯仁青 邮  箱：rqfeng@pku.edu.cn
职  称：副教授
办公室地址：北京市海淀区颐和园路5号，北京大学，金光生命科学大楼，100871
实验室地址：北京市海淀区颐和园路5号，北京大学，金光生命科学大楼，100871


个人简介
科研领域
代表性论文
教育经历:2000 - 2002 , 博士后，日本通商产业省生命研（Institute for Biological Resources and Functions, National Institute of Advanced Industrial Science and Technology, Central 6, Higashi, Tsukuba, Ibaraki, Japan）
1996 - 1999 , 医学博士，日本筑波大学基础医学院，生物化学与分子肿瘤学（Department of Biochemistry and Molecular Oncology, Institute of Basic Medical Sciences ，University of Tsukuba, Tsukuba, Ibaraki , Japan）
1988 - 1991 , 医学硕士，河北医科大学基础医学院，生物化学
1981 - 1986 , 医学学士, 河北医科大学， 医学系
荣誉奖励:北京大学教学优秀奖 ，2018
北京大学优秀班主任 , 2017
北京大学东宝教师奖 , 2016
北京大学东宝教师奖 , 2011
北京大学优秀班主任 , 2008
工作经历:2011 - 至今 , 博士生导师 , 北京大学生命科学学院
2002 - 至今 , 副教授 , 北京大学生命科学学院
执教课程:抗体技术及应用 , 主持 , 北京大学 , 2005-至今 秋季学期
生化与分子生物学进展 , 讲课 , 北京大学 , 2004-至今秋季学期
生物化学（下） , 讲课 , 北京大学 , 2002-2005
分子生物学实验 , 讲课 , 北京大学 , 2002-2004
分子肿瘤学
1.Cheng H, Wang S, Feng R*. STIM1 plays an important role in TGF-β-induced suppression of breast cancer cell proliferation. Oncotarget. 2016, 7(13): 16866-16878. DOI: 10.18632/oncotarget.7619 (*Corresponding author).
2.Yu Y, Yang R, Zhao X, Qin D, Liu Z, Liu F, Song X, Li L, Feng R*, Gao N*. Abrin P2 Suppresses Proliferation and Induces Apoptosis of Colon Cancer Cells via Mitochondrial Membrane Depolarization and Caspase Activation. Acta Biochimica et Biophysica Sinica, 2016, 48(5): 420-429.doi: 10.1093/abbs/gmw023(* Corresponding author).
3. Mahdi SHA.，Cheng H., Li J.,Feng R*. The effect of TGF-beta-induced epithelial-mesenchymal transition on the expression of intracellular calcium-handling proteins in T47D and MCF-7 human breast cancer cells. Archives of Biochemistry and Biophysics, 2015, 583: 18-26. doi: 10.1016/j.abb.2015.07.008 (* Corresponding author).
4. Liu X; Du L; Feng R* , c-Src regulates cell cycle proteins expression through protein kinase B/glycogen synthase kinase 3 beta and extracellular signal-regulated kinases 1/2 pathways in MCF-7 cells , Acta Biochimica et Biophysica Sinica , 2013 , 45: 586-592. doi: 10.1093/abbs/gmt042.(* Corresponding author).
5. Liu X, Feng R* , Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression , Acta Biochimica et Biophysica Sinica , 2010 , 42(7): 496-501. DOI: 10.1093/abbs/gmq043. (* Corresponding author).
6. Liu X，Feng R*, Du L. , The role of enoyl-CoA hydratase short chain 1 and peroxiredoxin 3 in PP2-induced apoptosis in human breast cancer MCF-7 cells. , FEBS Letters. , 2010 , 584: 3185-3192. DOI: 10.1016/j.febslet.2010.06.002 (*Corresponding author).
7. Feng R*, Guo Z , Li J. , Efficient purification of GP-1D8 glycoprotein from human breast carcinoma tissue by immunoaffinity chromatography , Preparative Biochemistry and Biotechnology , 2008 , 38(4): 321-333 (* Corresponding author).
8. Feng R*, Liu X, Guo Z , Li J. , Purification and characterization of 66-kDa glycoprotein from human breast carcinoma , Cancer Sci , 2007 , 98: 1344-1349（* Corresponding author).
9. Feng R*, Du L, Guo Z , In vitro cultivation and differentiation of fetal liver stem cells from mice , Cell Res. , 2005 , 15(5):401-405（* Corresponding author）.
10. Feng R, Kabayama A, Uchida K, Hoshino H, Miwa M. , Cell-free entry of human T-cell leukemia virus type 1 to mouse cells. , Jpn J Cancer Res , 2001 , 92(4):410-6.
11. Sun B, Feng R, Shoda M， Nitta T， Hanai S， Uchida K，Hoshino H, Miwa M , Cell-free HTLV-1 infection to mouse cells and expression , AIDS Research and Human Retrovirus , 2001 , 17(Suppl.1): S46-46
12. Feng R, Tanaka M, Abe H, Arashi N, Sun B, Uchida K, Miwa M. , Human T-cell leukemia virus type 1 can infect a wide variety of cells in mice , Jpn J Cancer Res , 1999 , 90(1):48-54
13. Fang J, Kushida S, Feng R, Tanaka M, Kawamura T, Abe H, Maeda N, Onobori M, Hori M, Uchida K, Miwa M. , Transmission of human T-cell leukemia virus type 1 to mice , J Virol , 1998 , 72(5):3952-7.
14. Fang J, Kushida S, Feng R, Tanaka M, Kikukawa H, Kawamura T, Uchida K, Miwa M. , Integration of HTLV-1 provirus into mouse transforming growth factor-alpha gene , Biochem Biophys Res Commun , 1997 , 233(3):792-5.